Literature DB >> 25480800

Cushing's syndrome: from physiological principles to diagnosis and clinical care.

Hershel Raff1, Ty Carroll.   

Abstract

The physiological control of cortisol synthesis in the adrenal cortex involves stimulation of adrenocorticotrophic hormone (ACTH) by hypothalamic corticotrophin-releasing hormone (CRH) and then stimulation of the adrenal by ACTH. The control loop of the hypothalamic-pituitary-adrenal (HPA) axis is closed by negative feedback of cortisol on the hypothalamus and pituitary. Understanding this system is required to master the diagnosis, differential diagnosis and treatment of endogenous hypercortisolism--Cushing's syndrome. Endogenous Cushing's syndrome is caused either by excess ACTH secretion or by autonomous cortisol release from the adrenal cortex. Diagnosis of cortisol excess exploits three physiological principles: failure to achieve the normal nadir in the cortisol diurnal rhythm, loss of sensitivity of ACTH-secreting tumours to cortisol negative feedback, and increased excretion of free cortisol in the urine. Differentiating a pituitary source of excess ACTH (Cushing's disease) from an ectopic source is accomplished by imaging the pituitary and sampling for ACTH in the venous drainage of the pituitary. With surgical removal of ACTH or cortisol-secreting tumours, secondary adrenal insufficiency ensues because of the prior suppression of the HPA axis by glucocorticoid negative feedback. Medical therapy is targeted to the anatomical location of the dysregulated component of the HPA axis. Future research will focus on new diagnostics and treatments of Cushing's syndrome. These are elegant examples of translational research: understanding basic physiology informs the development of new approaches to diagnosis and treatment. Appreciating pathophysiology generates new areas for inquiry of basic physiological and biochemical mechanisms.
© 2014 The Authors. The Journal of Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Year:  2015        PMID: 25480800      PMCID: PMC4324701          DOI: 10.1113/jphysiol.2014.282871

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  78 in total

1.  Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent.

Authors:  James W Findling; Michael E Kehoe; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 2.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

Review 3.  Update in the medical therapy of Cushing's disease.

Authors:  Lynnette K Nieman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-08       Impact factor: 3.243

4.  Ketoconazole as an adrenal steroidogenesis inhibitor: effectiveness and risks in the treatment of Cushing's disease.

Authors:  John Newell-Price
Journal:  J Clin Endocrinol Metab       Date:  2014-05       Impact factor: 5.958

Review 5.  Ectopic ACTH syndrome.

Authors:  Andrea M Isidori; Andrea Lenzi
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-11

6.  Late-night salivary cortisol as a screening test for Cushing's syndrome.

Authors:  H Raff; J L Raff; J W Findling
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

7.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

8.  Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome.

Authors:  Gabrielle Page-Wilson; Pamela U Freda; Thomas P Jacobs; Alexander G Khandji; Jeffrey N Bruce; Sandra T Foo; Kana Meece; Anne White; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

9.  Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis.

Authors:  Ty Carroll; Hershel Raff; James W Findling
Journal:  Endocr Pract       Date:  2009 May-Jun       Impact factor: 3.443

10.  Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Authors:  Gerald Goh; Ute I Scholl; James M Healy; Murim Choi; Manju L Prasad; Carol Nelson-Williams; John W Kunstman; John W Kuntsman; Reju Korah; Anna-Carinna Suttorp; Dimo Dietrich; Matthias Haase; Holger S Willenberg; Peter Stålberg; Per Hellman; Göran Akerström; Peyman Björklund; Tobias Carling; Richard P Lifton
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

View more
  17 in total

1.  The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis.

Authors:  Christina Glantschnig; Frits Mattijssen; Elena Sophie Vogl; Asrar Ali Khan; Marcos Rios Garcia; Katrin Fischer; Timo Müller; Henriette Uhlenhaut; Peter Nawroth; Marcel Scheideler; Adam J Rose; Natalia Pellegata; Stephan Herzig
Journal:  EMBO Rep       Date:  2019-09-26       Impact factor: 8.807

2.  Early post-natal life stress induces permanent adrenocorticotropin-dependent hypercortisolism in male mice.

Authors:  Luca Persani; Iacopo Chiodini; Gabriele Campana; Stefano Loizzo; Andrea Fortuna; Roberto Rimondini; Zaira Maroccia; Alfredo Scillitani; Alberto Falchetti; Santi Mario Spampinato
Journal:  Endocrine       Date:  2021-02-25       Impact factor: 3.633

3.  E2F1-mediated human POMC expression in ectopic Cushing's syndrome.

Authors:  Takako Araki; Ning-Ai Liu; Yukiko Tone; Daniel Cuevas-Ramos; Roy Heltsley; Masahide Tone; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2016-10-07       Impact factor: 5.678

Review 4.  Consensus on diagnosis and management of Cushing's disease: a guideline update.

Authors:  Maria Fleseriu; Richard Auchus; Irina Bancos; Anat Ben-Shlomo; Jerome Bertherat; Nienke R Biermasz; Cesar L Boguszewski; Marcello D Bronstein; Michael Buchfelder; John D Carmichael; Felipe F Casanueva; Frederic Castinetti; Philippe Chanson; James Findling; Mônica Gadelha; Eliza B Geer; Andrea Giustina; Ashley Grossman; Mark Gurnell; Ken Ho; Adriana G Ioachimescu; Ursula B Kaiser; Niki Karavitaki; Laurence Katznelson; Daniel F Kelly; André Lacroix; Ann McCormack; Shlomo Melmed; Mark Molitch; Pietro Mortini; John Newell-Price; Lynnette Nieman; Alberto M Pereira; Stephan Petersenn; Rosario Pivonello; Hershel Raff; Martin Reincke; Roberto Salvatori; Carla Scaroni; Ilan Shimon; Constantine A Stratakis; Brooke Swearingen; Antoine Tabarin; Yutaka Takahashi; Marily Theodoropoulou; Stylianos Tsagarakis; Elena Valassi; Elena V Varlamov; Greisa Vila; John Wass; Susan M Webb; Maria C Zatelli; Beverly M K Biller
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-20       Impact factor: 32.069

5.  Posterior reversible encephalopathy syndrome in carcinoid tumor.

Authors:  Thuy-Tien Ho; Venkatesh Aiyagari
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-04-19

6.  Pituitary tumor centers of excellence for Cushing's disease.

Authors:  Marcos Couselo; Stefano Frara; Andrea Giustina; Felipe F Casanueva
Journal:  Pituitary       Date:  2022-09-10       Impact factor: 3.599

Review 7.  Interactions between emotions and eating behaviors: Main issues, neuroimaging contributions, and innovative preventive or corrective strategies.

Authors:  Nicolas Coquery; David Val-Laillet; Ambre Godet; Alexandra Fortier; Elise Bannier
Journal:  Rev Endocr Metab Disord       Date:  2022-01-04       Impact factor: 9.306

8.  Differential off-target glucocorticoid activity of progestins used in endocrine therapy.

Authors:  Maleshigo Komane; Chanel Avenant; Renate Louw-du Toit; Donita J Africander; Janet P Hapgood
Journal:  Steroids       Date:  2022-03-07       Impact factor: 2.760

9.  Maternal Diet Supplementation with n-6/n-3 Essential Fatty Acids in a 1.2 : 1.0 Ratio Attenuates Metabolic Dysfunction in MSG-Induced Obese Mice.

Authors:  Josiane Morais Martin; Rosiane Aparecida Miranda; Luiz Felipe Barella; Kesia Palma-Rigo; Vander Silva Alves; Gabriel Sergio Fabricio; Audrei Pavanello; Claudinéia Conationi da Silva Franco; Tatiane Aparecida Ribeiro; Jesuí Vergílio Visentainer; Elton Guntendeorfer Banafé; Clayton Antunes Martin; Paulo Cezar de Freitas Mathias; Júlio Cezar de Oliveira
Journal:  Int J Endocrinol       Date:  2016-12-05       Impact factor: 3.257

Review 10.  Screening for Cushing Syndrome at the Primary Care Level: What Every General Practitioner Must Know.

Authors:  Ernest Yorke; Yacoba Atiase; Josephine Akpalu; Osei Sarfo-Kantanka
Journal:  Int J Endocrinol       Date:  2017-07-27       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.